Related Experiment Video
Updated: Jan 25, 2026

In Vitro Characterization of Histone Chaperones using Analytical, Pull-Down and Chaperoning Assays
Published on: December 29, 2021
Analytical characterization of the Siemens Dimension EXL high-sensitivity cardiac troponin I assay
Peter A Kavsak1, Jackie MacCuish2, Jill Boreyko2
1Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada; Core Laboratory, Hamilton Health Sciences, Hamilton, ON, Canada.
Insights
The Siemens Dimension EXL high-sensitivity troponin I (hs-cTnI) assay demonstrates analytical performance meeting high-sensitivity criteria. Assay-specific cutoffs are crucial for optimizing clinical utility and patient outcomes.
Area of Science:
- Clinical Chemistry
- Cardiovascular Diagnostics
- Biomarker Assay Development
Background:
- Siemens Healthcare Diagnostics offers multiple cardiac troponin I (cTnI) assays with varying methodologies.
- This study evaluates the analytical performance of the Dimension EXL hs-cTnI assay using the LOCI method.
Purpose of the Study:
- To assess the analytical performance of the Siemens Dimension EXL hs-cTnI assay.
- To compare the Dimension EXL hs-cTnI assay with other high-sensitivity troponin I assays (ADVIA Centaur and Abbott ARCHITECT) across different biological matrices.
Main Methods:
- Determined analytical sensitivity and precision of the Dimension EXL hs-cTnI assay below the 99th percentile.
- Conducted method comparisons between Dimension EXL contemporary cTnI and hs-cTnI assays.
- Performed cross-matrix comparisons (serum, lithium heparin, EDTA plasma) for the EXL hs-cTnI assay.
- Compared the EXL hs-cTnI assay against ADVIA Centaur and Abbott ARCHITECT hs-cTnI assays using non-parametric analyses.
Main Results:
- The Dimension EXL hs-cTnI assay exhibited a limit of detection of 1.7 ng/L and imprecision below 5.8%.
- Comparisons revealed proportional differences in troponin I concentrations between assays and matrices, particularly at higher concentrations.
- The EXL hs-cTnI assay showed higher concentrations compared to Abbott ARCHITECT hs-cTnI in EDTA plasma and across all matrices below 100 ng/L.
Conclusions:
- The Siemens Dimension EXL hs-cTnI assay meets the analytical requirements for high-sensitivity troponin detection.
- Establishing assay-specific cutoffs is essential for maximizing the clinical performance and diagnostic accuracy of the Dimension EXL hs-cTnI assay.
Background:
Siemens Healthcare Diagnostics has four commercially available assays on different analytical platforms using different methodologies to generate signal. We assessed the analytical performance of the Dimension EXL hs-cTnI assay (LOCI method) across different matrices and compared it to two different acridinium ester-based hs-cTnI assays (ADVIA Centaur and Abbott ARCHITECT).
Methods:
The analytical sensitivity and precision below the 99th-percentile was determined for the Dimension EXL hs-cTnI assay. Method comparisons were performed between the Dimension EXL contemporary cTnI and the hs-cTnI assays, between different matrices for the EXL hs-cTnI assay (serum, lithium heparin and EDTA plasma), and between different hs-cTnI assays (EXL versus ADVIA Centaur or Abbott ARCHITECT) using non-parametric analyses.
Results:
The limit of blank and detection were 0.9 ng/L and 1.7 ng/L, respectively, with imprecision of 5.8% at 8.6 ng/L and 3.2% at 47.5 ng/L. Comparison between the EXL contemporary cTnI and hs-cTnI assay (range: 2.6-4214 ng/L) yielded proportional lower concentrations for the hs-cTnI assay (slope = 0.86; 95%CI: 0.81 to 0.96, n = 40); however, there was no difference in concentrations below 100 ng/L between the assays (median difference = -2.7 ng/L; 95%CI: -9.8 to 9.3). Passing-Bablok regression analysis with EDTA plasma yielded proportionally higher concentrations with the EXL hs-cTnI versus Abbott hs-cTnI (slope = 1.45; 95%CI: 1.02-1.86, n = 40) with proportionally lower concentrations with EDTA versus lithium heparin plasma with the EXL hs-cTnI assay alone (slope = 0.93; 95%CI: 0.90 to 0.99, n = 40). Comparison with Abbott hs-cTnI concentrations below 100 ng/L in the three matrices, indicated that the EXL hs-cTnI assay yielded higher concentrations (median difference range: 3.4-9.4 ng/L), with differences also evident when comparing the EXL hs-cTnI assay to the ADVIA Centaur hs-cTnI assay.
Conclusion:
The Siemens EXL hs-cTnI assay meets the analytical criteria for a high-sensitivity assay, with assay specific cutoffs important to maximize clinical performance.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
Related Concept Videos
Support Reactions in Three Dimensions
Ball and Socket Joint is one of the supports allowing free rotation about any axis. This freedom of rotation is...
Relative Velocity in One Dimension
Development of Analytical Methods
Relative Velocity in Two Dimensions
Dimensions of Health and Illness
Equations of Equilibrium in Three Dimensions
According to the vector equations of equilibrium, the vector sum of all the external forces acting on a body must...